The Pharmacy and Poisons Board (PPB) has issued an alert regarding falsified cancer and kidney transplant drugs, IBRANCE (palbociclib) and SIMULECT (basiliximab), following a World Health Organization (WHO) notification.

• Nine batches of falsified IBRANCE (cancer drug), with batches like FS5173 and GS4328, were confirmed counterfeit or highly suspicious.
• The falsified SIMULECT (immunosuppressant for organ transplant) carries batch number SFYD2.
• The PPB has not detected these falsified drugs in Kenya but issued the alert as a precautionary measure.
• The Board urged all stakeholders, including procurement agencies, hospitals, and the public, to report any encounters with these products.